Bill > HR5435

This bill aims to establish a comprehensive national screening program for congenital Cytomegalovirus (CMV), a viral infection that can cause serious health problems in newborns. The bill would require hospitals and healthcare entities caring for infants 21 days old or younger to administer CMV tests, with each state's chief health executive responsible for developing standards and procedures for testing, result tracking, and information dissemination to parents. If a state fails to create its own protocols within two years, the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children will develop and implement standards. The bill also provides funding through grants to states from three key federal agencies: the Health Resources and Services Administration (to support testing), the Centers for Disease Control and Prevention (to improve data collection and provide public education), and the National Institutes of Health (to conduct research on screening techniques, diagnostics, prevention, and potential treatments for CMV). Additionally, the bill expands the role of the Advisory Committee to include overseeing CMV-related activities, with the ultimate goal of improving early detection, understanding, and management of this potentially serious newborn health condition.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5435/all-info